Title |
Human Albumin Fragments Nanoparticles as PTX Carrier for Improved Anti-cancer Efficacy
|
---|---|
Published in |
Frontiers in Pharmacology, June 2018
|
DOI | 10.3389/fphar.2018.00582 |
Pubmed ID | |
Authors |
Liang Ge, Xinru You, Jun Huang, Yuejian Chen, Li Chen, Ying Zhu, Yuan Zhang, Xiqiang Liu, Jun Wu, Qian Hai |
Abstract |
For enhanced anti-cancer performance, human serum albumin fragments (HSAFs) nanoparticles (NPs) were developed as paclitaxel (PTX) carrier in this paper. Human albumins were broken into fragments via degradation and crosslinked by genipin to form HSAF NPs for better biocompatibility, improved PTX drug loading and sustained drug release. Compared with crosslinked human serum albumin NPs, the HSAF-NPs showed relative smaller particle size, higher drug loading, and improved sustained release. Cellular and animal results both indicated that the PTX encapsulated HSAF-NPs have shown good anti-cancer performance. And the anticancer results confirmed that NPs with fast cellular internalization showed better tumor inhibition. These findings will not only provide a safe and robust drug delivery NP platform for cancer therapy, but also offer fundamental information for the optimal design of albumin based NPs. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 27 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 26% |
Student > Master | 3 | 11% |
Researcher | 3 | 11% |
Student > Bachelor | 2 | 7% |
Professor | 1 | 4% |
Other | 3 | 11% |
Unknown | 8 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 6 | 22% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 11% |
Biochemistry, Genetics and Molecular Biology | 3 | 11% |
Chemical Engineering | 2 | 7% |
Engineering | 2 | 7% |
Other | 4 | 15% |
Unknown | 7 | 26% |